atropine has been researched along with pergolide in 7 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (pergolide) | Trials (pergolide) | Recent Studies (post-2010) (pergolide) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 845 | 123 | 87 |
| Protein | Taxonomy | atropine (IC50) | pergolide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.379 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.385 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.264 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.2 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.111 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.385 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.064 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.41 | |
| D | Rattus norvegicus (Norway rat) | 0.0031 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.2 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.041 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.0603 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.679 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.041 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.041 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.513 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.014 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.379 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.2 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 0.385 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | 0.385 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0054 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.385 | |
| Alpha-synuclein | Homo sapiens (human) | 7.9 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.076 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.039 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1202 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 0.385 | |
| D | Bos taurus (cattle) | 0.0603 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.385 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.385 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jandhyala, BS; Kivlighn, SD; Lokhandwala, MF | 1 |
| Johnson, KM; Leventer, SM | 1 |
| Connell, TA; Weiss, B; Zhang, SP; Zhou, LW | 1 |
| Prokopec, V; Švecová, M; Volochanskyi, O | 1 |
1 review(s) available for atropine and pergolide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for atropine and pergolide
| Article | Year |
|---|---|
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Topics: Animals; Antiparkinson Agents; Atropine; Blood Pressure; Brain; Dogs; Ergolines; Female; Hindlimb; Male; Norepinephrine; Pergolide; Receptors, Dopamine; Sulpiride; Sympathetic Nervous System; Vascular Resistance; Vasodilation | 1984 |
Effects of phencyclidine on the release of radioactivity from rat striatal slices labeled with [3H]choline.
Topics: Acetylcholine; Amphetamine; Animals; Atropine; Calcium; Choline; Corpus Striatum; Dose-Response Relationship, Drug; Ergolines; Male; Oxotremorine; Pergolide; Phencyclidine; Rats; Rats, Inbred Strains | 1983 |
AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
Topics: Animals; Apomorphine; Atropine; Aziridines; Benzazepines; Choline; Corpus Striatum; Dopamine Agents; Functional Laterality; Male; Mice; Motor Activity; Neuromuscular Blocking Agents; Oxotremorine; Parasympathomimetics; Pergolide; Receptors, Dopamine D2; Receptors, Muscarinic; Rotation; Sulpiride | 1993 |
Detection and identification of medically important alkaloids using the surface-enhanced Raman scattering spectroscopy.
Topics: Adjuvants, Anesthesia; Atropine; Dopamine Agonists; Gold; Least-Squares Analysis; Pergolide; Silver; Spectrum Analysis, Raman | 2019 |